Currently, Amedisys Inc [AMED] is trading at $84.97, down -0.47%. An important factor to consider is whether the stock is rising or falling in short-term value. The AMED shares have lost -0.65% over the last week, with a monthly amount drifted -5.01%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Amedisys Inc [NASDAQ: AMED] stock has seen the most recent analyst activity on July 29, 2024, when Deutsche Bank downgraded its rating to a Hold but kept the price target unchanged to $101 for it. Previously, William Blair downgraded its rating to Mkt Perform on July 01, 2024. On June 07, 2023, downgrade downgraded it’s rating to Hold but maintained its price target of $97 on the stock. Cantor Fitzgerald started tracking the stock assigning a Neutral rating and suggested a price target of $87 on April 21, 2023. Barclays initiated its recommendation with a Equal Weight and recommended $93 as its price target on March 13, 2023. Raymond James downgraded its rating to Mkt Perform for this stock on October 27, 2022. In a note dated August 02, 2022, UBS downgraded an Sell rating on this stock and revised its target price from $145 to $95.
This stock has fluctuated between a low of $84.06 and a high of $98.95 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $143.38 within the next 12 months. Amedisys Inc [NASDAQ: AMED] shares were valued at $84.97 at the most recent close of the market. An investor can expect a potential return of 68.74% based on the average AMED price forecast.
Analyzing the AMED fundamentals
Trailing Twelve Months sales for Amedisys Inc [NASDAQ:AMED] were 2.32B which represents 5.65% growth. Gross Profit Margin for this corporation currently stands at 0.4% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.12 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 84.78 points at the first support level, and at 84.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 85.36, and for the 2nd resistance point, it is at 85.75.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Amedisys Inc [NASDAQ:AMED] is 1.19. On the other hand, the Quick Ratio is 1.19, and the Cash Ratio is 0.51. Considering the valuation of this stock, the price to sales ratio is 1.20, the price to book ratio is 2.42 and price to earnings (TTM) ratio is 33.83.
Transactions by insiders
Recent insider trading involved North Michael Paul, Former Officer, that happened on Nov 07 ’24 when 11221.0 shares were purchased.
